Share on StockTwits

SciClone Pharmaceuticals (NASDAQ:SCLN) is scheduled to post its Q214 quarterly earnings results on Monday, August 11th. Analysts expect SciClone Pharmaceuticals to post earnings of $0.10 per share and revenue of $33.40 million for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

SciClone Pharmaceuticals (NASDAQ:SCLN) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.10 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.08 by $0.02. The company had revenue of $26.60 million for the quarter, compared to the consensus estimate of $32.20 million. During the same quarter last year, the company posted $0.08 earnings per share. SciClone Pharmaceuticals’s revenue was down 10.7% compared to the same quarter last year. On average, analysts expect SciClone Pharmaceuticals to post $0.40 EPS for the current fiscal year and $0.52 EPS for the next fiscal year.

SciClone Pharmaceuticals (NASDAQ:SCLN) opened at 4.92 on Friday. SciClone Pharmaceuticals has a 52 week low of $4.24 and a 52 week high of $6.09. The stock has a 50-day moving average of $5.09 and a 200-day moving average of $4.86. The company has a market cap of $253.3 million and a P/E ratio of 25.13.

SciClone Pharmaceuticals, Inc (NASDAQ:SCLN) is a specialty pharmaceutical company.

Receive News & Ratings for SciClone Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SciClone Pharmaceuticals Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.